Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 1,132	$ 574
Accounts receivable (net of allowance for doubtful accounts of $13 in 2026 and $12 in 2025)	1,492	1,331
Inventories (excludes inventories of $273 in 2026 and $236 in 2025 classified in Other assets)	1,351	1,406
Other current assets	1,136	1,033
Assets held for sale	0	8
Total Current Assets	5,111	4,352
Property, plant and equipment, net	1,281	1,303
Goodwill	4,153	4,153
Intangibles, net	1,112	1,130
Other assets	1,521	1,539
Noncurrent assets held for sale	0	390
Total Assets	13,178	12,867
Current Liabilities:
Current portion of long-term debt and short-term borrowings	74	16
Trade accounts payable	1,051	952
Accrued and other current liabilities	1,407	1,335
Income taxes payable	84	85
Liabilities held for sale	0	2
Total Current Liabilities	2,616	2,390
Long-term debt	8,479	8,628
Deferred income taxes	51	57
Other noncurrent liabilities	1,026	1,008
Noncurrent liabilities held for sale	0	32
Total Liabilities	12,172	12,115
Contingencies (Note 15)
Organon & Co. Stockholders’ Equity:
Common stock, $0.01 par value Authorized - 500,000 Issued and outstanding - 262,609 in 2026 and 260,316 in 2025	3	3
Additional paid-in capital	199	167
Retained earnings	1,352	1,109
Accumulated other comprehensive loss	(548)	(527)
Total Stockholders’ Equity	1,006	752
Total Liabilities and Stockholders’ Equity	$ 13,178	$ 12,867

Accrued And Other Liabilities, Current

No definition available.

Name:	ogn_AccruedAndOtherLiabilitiesCurrent
Namespace Prefix:	ogn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).